| Class 2 Device Recall Wako TASWako i30 | |
Date Initiated by Firm | February 18, 2021 |
Create Date | April 13, 2021 |
Recall Status1 |
Terminated 3 on February 24, 2022 |
Recall Number | Z-1412-2021 |
Recall Event ID |
87507 |
510(K)Number | K100464 |
Product Classification |
Test, alpha fetoprotein l3 subfraction (afp-l3%), for hepatocellular carcinoma risk assessment - Product Code NSF
|
Product | TASWako Chip Cassette is part of the Wako TASWako i30 kit |
Code Information |
Lot Number: EQ194 Exp. Date: 05/31/2022 |
Recalling Firm/ Manufacturer |
Fujifilm Medical Systems U.S.A., Inc. 81 Hartwell Ave Ste 300 Lexington MA 02421-3160
|
For Additional Information Contact | SAME 617-861-5300 |
Manufacturer Reason for Recall | Potentially defective Chip Cassette units, when used for DCP or AFP-L3% measurement, incorrect DCP and AFP-L3% values may result |
FDA Determined Cause 2 | Under Investigation by firm |
Action | Fujifilm issued Consignee notifications via courier delivery and electronic mail on February 18, 2021. The letter states reason for recall, health risk and action to take: FUJIFILM is recommending that you immediately cease use of any Cavity #2 chips in Lot EQ194 and return the product to FUJIFILM.
Please complete and return the Field Action Verification Form attached on page 3 of this communication. Providing the response with the information requested is essential for ensuring appropriate action is taken:
Upon receipt of the Field Action Verification Form, FUJIFILM will provide replacement chip cassette boxes (each containing 5 x 20 chips) from a different lot.
Please contact our field action coordinator, Jeffrey Wan, via phone at 201-675-8947 or email at jeffrey.wan@fujifilm.com, if you have any further questions regarding this field action. |
Quantity in Commerce | 496 units |
Distribution | CA, LA, MN, NC, UT, WI |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
510(K) Database | 510(K)s with Product Code = NSF
|
|
|
|